What To Watch As FTC Opens New Front On Generic Delays
The Federal Trade Commission's first-of-its-kind lawsuit alleging abuse of the U.S. Food and Drug Administration's citizen petition process will shed light on when drugmaker efforts to delay generic competition cross a...To view the full article, register now.
Already a subscriber? Click here to view full article